4.
    发明专利
    未知

    公开(公告)号:DE59501795D1

    公开(公告)日:1998-05-14

    申请号:DE59501795

    申请日:1995-01-09

    Applicant: BAYER AG

    Abstract: Control of endoparasites in human beings and animals comprises admin. of cyclic depsipeptide of formula (I); R ,R = H or opt. substd. alkyl, cycloalkyl, aralkyl, aryl, heteroaryl or heteroarylalkyl; R ,R ,R ,R = H; 1-8C alkyl; haloalkyl; HO-alkyl; alkanoylalkyl; alkoxyalkyl; aryloxyalkyl; HS-alkyl; alkylthioalkyl; alkylsulphinylalkyl; alkylsulphonylalkyl; COOH-alkyl; alkoxycarbonylalkyl; arylalkoxycarbonylalkyl; carbamoylalkyl; H2N-alkyl opt. N-mono- or N,N-di-substd. by alkyl; guanidinoalkyl opt. mono- or di-substd. by BzO-CO- or mono- to tetra-substd. by alkyl; alkoxycarbonylaminoalkyl; Fmoc-aminoalkyl; alkenyl; cycloalkyl; cycloalkylalkyl; or opt. substd. aryl, aralkyl, heteroaryl or heteroarylalkyl. Known cpds. (I) are described in J.A.C.S. 91(1969), p. 4888; Biorg. Khim. 1 (1975), 375; Biofizica 16 (1971) p. 407; and lav. Akad. Nark. SCSR, Set Khim, 1970, p. 991. (I) have good mammalian toxicity and can be used to control pathogenic endoparasites such as cestodes, trematodes, nematodes and acantocephales, e.g. Taenia, Dactylogyrus, Schistosoma, Fasciola, Trichomosoides, Strondyloides, Filaroides, Enterobius and Toxocara spp. (I) are pref. used in veterinary medicine to treat e.g. domestic pets, farm, zoo and laboratory animals, poultry, fish and insects such as honey bees and silkworms. (I) can also be used therapeutically or prophylactically in the form of conventional formulations, e.g. powders, tablets or medicated feed, and may be administered by the enteral, parenteral, nasal or transdermal route. (I) are more active in controlling worm diseases than prior art cpds.

    10.
    发明专利
    未知

    公开(公告)号:ES2115269T3

    公开(公告)日:1998-06-16

    申请号:ES95100198

    申请日:1995-01-09

    Applicant: BAYER AG

    Abstract: Control of endoparasites in human beings and animals comprises admin. of cyclic depsipeptide of formula (I); R ,R = H or opt. substd. alkyl, cycloalkyl, aralkyl, aryl, heteroaryl or heteroarylalkyl; R ,R ,R ,R = H; 1-8C alkyl; haloalkyl; HO-alkyl; alkanoylalkyl; alkoxyalkyl; aryloxyalkyl; HS-alkyl; alkylthioalkyl; alkylsulphinylalkyl; alkylsulphonylalkyl; COOH-alkyl; alkoxycarbonylalkyl; arylalkoxycarbonylalkyl; carbamoylalkyl; H2N-alkyl opt. N-mono- or N,N-di-substd. by alkyl; guanidinoalkyl opt. mono- or di-substd. by BzO-CO- or mono- to tetra-substd. by alkyl; alkoxycarbonylaminoalkyl; Fmoc-aminoalkyl; alkenyl; cycloalkyl; cycloalkylalkyl; or opt. substd. aryl, aralkyl, heteroaryl or heteroarylalkyl. Known cpds. (I) are described in J.A.C.S. 91(1969), p. 4888; Biorg. Khim. 1 (1975), 375; Biofizica 16 (1971) p. 407; and lav. Akad. Nark. SCSR, Set Khim, 1970, p. 991. (I) have good mammalian toxicity and can be used to control pathogenic endoparasites such as cestodes, trematodes, nematodes and acantocephales, e.g. Taenia, Dactylogyrus, Schistosoma, Fasciola, Trichomosoides, Strondyloides, Filaroides, Enterobius and Toxocara spp. (I) are pref. used in veterinary medicine to treat e.g. domestic pets, farm, zoo and laboratory animals, poultry, fish and insects such as honey bees and silkworms. (I) can also be used therapeutically or prophylactically in the form of conventional formulations, e.g. powders, tablets or medicated feed, and may be administered by the enteral, parenteral, nasal or transdermal route. (I) are more active in controlling worm diseases than prior art cpds.

Patent Agency Ranking